Current Classification and Management Strategies in CIDP
Anders Svenningsson, MD, PhD, Professor of Neurology at Karolinska Institutet, discusses the evolving classification of CIDP and its clinical implications. He reviews diagnostic strategies, including neurophysiology and CSF analysis, and highlights how disease variants and antibody profiles guide treatment decisions—from IVIG and steroids to emerging options.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in